Guggenheim Maintains Buy on Eli Lilly, Raises Price Target to $401
Guggenheim analyst Seamus Fernandez maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $399 to $401.
Related Posts
UBS Maintains Neutral on Ross Stores, Raises Price Target to $108
UBS analyst Jay Sole maintains Ross Stores (NASDAQ:ROST) with a Neutral and raises the price target from $92 to $108.
Summarizing 2Q22 Internet App Data, Google Search Trends Analysis By Raymond James
Raymond James analyst Aaron Kessler reviewed 2Q App data trends and Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google Search Trends data across local…
Tesla ‘Seeing A Lot More Pressure’ On Margins, Says Ford CEO
Ford Motor Co (NYSE:F) CEO Jim Farley on Monday expressed confidence in matching up with Tesla Inc (NASDAQ:TSLA)…